16th July 2026, Thursday

TechPharus

Latest Posts

HealthTech News

  • New images map key membrane protein in brain related to stroke
    on July 16, 2026 at 7:30 pm

    Scientists have, for the first time, mapped in exquisite three-dimensional detail six major conformations of a membrane in the brain related to learning, memory and fear-related behavior.

  • Simple antiseptic approach could help prevent deadly infections in newborn babies
    on July 16, 2026 at 7:20 pm

    A low-cost antiseptic treatment routinely used in health care settings could help reduce the risk of life-threatening infections in newborn babies, according to new research led by scientists at City St George’s.

  • A chat with a veterinarian may help smokers kick the habit
    on July 16, 2026 at 7:20 pm

    When a dog smells of cigarette smoke, veterinarians immediately understand that the animal is breathing in secondhand smoke. Known as a “smoker’s poodle,” the pet “presumably sits on somebody’s lap as they smoke, and we think, ‘Oh, this is bad for the animal,'” says Elizabeth Rozanski, D.V.M., DACVIM (SAIM), DACVECC, a professor of small animal clinical sciences at Cummings School of Veterinary Medicine at Tufts University.

  • Public health leadership needs to build trustworthy AI in health, expert argues
    on July 16, 2026 at 7:00 pm

    From disease surveillance to clinical care, artificial intelligence is transforming health. As AI becomes more deeply embedded in decisions affecting population health, a new editorial argues that realizing AI’s full potential requires public health leadership alongside technical innovation.

  • Targeting RBM5 may help disrupt ‘undruggable’ MYC in childhood leukemia
    on July 16, 2026 at 7:00 pm

    Scientists from St. Jude Children’s Research Hospital and collaborators have identified the RNA-binding protein RBM5 as a potential vulnerability in a set of difficult-to-treat childhood leukemias. They characterized how RBM5 regulates and interacts with the well-known cancer-driving protein MYC, which has long been considered impossible to effectively and directly target with existing cancer drugs. The findings, published today in Leukemia, present a new opportunity to develop targeted therapeutic interventions.